Sanofi has reported a robust financial performance for fiscal year 2025, with net sales rising 9.9% to reach €43.6 billion... Read more
Tag: #Global Trends
AstraZeneca and CSPC Pharmaceuticals enter $4.7 billion obesity drug collaboration
AstraZeneca has announced a strategic collaboration with China’s CSPC Pharmaceutical Group, worth up to $4.7 billion. The partnership covers eight... Read more
Eli Lilly unveils $3.5B Pennsylvania plant, rounding out U.S. manufacturing expansion quartet
On January 30, 2026, Eli Lilly announced plans to invest over $3.5 billion in a state-of-the-art injectable medicine and device... Read more
Regeneron’s Eylea franchise faces continued sales decline through Q1 2026
In its Q4 and full-year 2025 financial presentation, Regeneron Pharmaceuticals disclosed that the downward trend in U.S. sales for its... Read more
EMA issues new recommendations: Advances in liver treatment and data integrity challenges
In its latest meeting in late January 2026, the EMA’s Committee for Medicinal Products for Human Use (CHMP) released pivotal... Read more
Internal debate surfaces within U.S. administration over COVID-19 vaccine future
Recent reports indicate a growing divide among health officials in the U.S. administration regarding whether COVID-19 vaccines should be removed... Read more
Singapore and Germany expand infant formula recalls over toxin concerns
Food safety authorities in Singapore and Germany have recently issued expanded recall notices for several batches of Dumex and Aptamil... Read more
Boehringer Ingelheim secures licensing deal for Chinese IBD drug candidate in billion-euro pact
German pharmaceutical giant Boehringer Ingelheim has entered into a licensing agreement with China's Simcere Pharmaceutical Group to develop an experimental... Read more
Novo Nordisk intensifies hunt for next-generation obesity innovations
At the 2026 J.P. Morgan Healthcare Conference, Novo Nordisk signaled its dominance with its largest-ever presence, conducting over 200 partner... Read more









